V009-2773 Screening compound: 3-cyclopentyl-N-{[3-ethyl-1-(4-fluorophenyl)-5-[4-(propan-2-yl)piperazin-1-yl]-1H-pyrazol-4-yl]methyl}-N-(2-methylpropyl)propanamide

V009-2773 Screening compound: 3-cyclopentyl-N-{[3-ethyl-1-(4-fluorophenyl)-5-[4-(propan-2-yl)piperazin-1-yl]-1H-pyrazol-4-yl]methyl}-N-(2-methylpropyl)propanamide
V009-2773 Screening compound: 3-cyclopentyl-N-{[3-ethyl-1-(4-fluorophenyl)-5-[4-(propan-2-yl)piperazin-1-yl]-1H-pyrazol-4-yl]methyl}-N-(2-methylpropyl)propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V009-2773
3-cyclopentyl-N-{[3-ethyl-1-(4-fluorophenyl)-5-[4-(propan-2-yl)piperazin-1-yl]-1H-pyrazol-4-yl]methyl}-N-(2-methylpropyl)propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V009-2773

Molecular Formula

C31H48FN5O (C31 H48 FN5 O)

Compound Name

3-cyclopentyl-N-{[3-ethyl-1-(4-fluorophenyl)-5-[4-(propan-2-yl)piperazin-1-yl]-1H-pyrazol-4-yl]methyl}-N-(2-methylpropyl)propanamide

IUPAC name

3-cyclopentyl-N-{[3-ethyl-1-(4-fluorophenyl)-5-[4-(propan-2-yl)piperazin-1-yl]-1H-pyrazol-4-yl]methyl}-N-(2-methylpropyl)propanamide

SMILES

CCc(c(CN(CC(C)C)C(CCC1CCCC1)=O)c1N(CC2)CCN2C(C)C)nn1-c(cc1)ccc1F

InChI

InChI=1S/C31H48FN5O/c1-6-29-28(22-36(21-23(2)3)30(38)16-11-25-9-7-8-10-25)31(35-19-17-34(18-20-35)24(4)5)37(33-29)27-14-12-26(32)13-15-27/h12-15,23-25H,6-11,16-22H2,1-5H3

InChI Key

MDUOWDDQNWGGFO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19942054

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

525.75

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

6.510

Distribution Coefficient, logD

4.081

Water Solubility, LogSw

-5.68

Polar Surface Area

37.709

Acid Dissociation Constant (pKa)

23.91

Base Dissociation Constant (pKb)

9.83

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

67.70

V009-2773 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with V009-2773 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V009-2773?
Check Price and Availability of V009-2773, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V009-2773 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V009-2773
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V009-2773
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V009-2773 available by request